Accolade

Accolade Enterprise Value

Delisted

The Enterprise Value (EV) of Accolade (ACCD) as of Oct 14, 2026 is 554.13 M USD. In the previous year, Enterprise Value (EV) was 537.41 M USD — a change of 3.11% (higher).

Enterprise Value

554.13 MUSD

YoY

3.11%

Last updated:

Enterprise Value (EV) of Accolade is 2024 554.13 M USD. Enterprise Value (EV) of Accolade was 2023 537.41 M USD. It decreases by 3.11% higher compared to the previous year.

The Accolade Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
582.96 M USD
Jan 1, 2019
552.09 M USD
Jan 1, 2020
512.37 M USD
Jan 1, 2021
141.71 M USD
Jan 1, 2022
491.04 M USD
Jan 1, 2023
537.41 M USD
Jan 1, 2024
554.13 M USD
The Accolade Enterprise Value history
YEAREnterprise ValueYoY
554.13 MUSD+3.11%
537.41 MUSD+9.44%
491.04 MUSD+246.52%
141.71 MUSD-72.34%
512.37 MUSD-7.19%
552.09 MUSD-5.29%
582.96 MUSD—
Access this data via the Eulerpool API

Accolade Stock analysis

What does Accolade do? Accolade Inc is a US-American company based in Seattle. The company was founded in 2007 by Rajeev Singh and Mike Hilton and has since developed into a leading healthcare consulting firm. Accolade aims to make healthcare simple and affordable for everyone. The company offers a wide range of solutions to its customers. It provides services to employers, insurance companies, and health authorities. Their main focus is on supporting patients and employees in their healthcare. They also offer services to health insurance companies and health authorities. The business model of Accolade involves close collaboration between the customers and the company. Patients are supported by a "Health Assistant," who are trained professionals that help patients make the best decisions regarding their health. Factors such as finding the best providers, medication delivery, clinical tests, and alternative options are considered. Accolade's mission is to improve healthcare for everyone by providing the best solutions. The company has divided itself into several different divisions to offer its services more effectively. The various divisions of Accolade include healthcare consulting, medication management, patient access and health navigation, client support, and health optimization. Accolade has become an important healthcare service provider and has earned a good reputation in the industry. The company is known for providing comprehensive and high-quality services that focus on individual patient care. When it comes to achieving improvements in care and the entire healthcare system, Accolade is an important partner that helps companies and individuals achieve their goals and lead healthier lives. Accolade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accolade stock

Enterprise Value (EV) of Accolade is 554.13 M USD in 2024.

Enterprise Value (EV) of Accolade changed from 537.41 M USD to 554.13 M USD, representing a 3.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Accolade since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Accolade with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Accolade

All Key Metrics — Accolade